グリコシル化ヘモグロビンCペプチドのグローバル市場インサイト・予測（～2028年）

• レポートコード： • 出版社/出版日： / • レポート形態：、、ページ数はお問い合わせください。 • 納品方法：

• 販売価格（消費税別）

￥ 日本円の価格はお問い合わせください。 (0)

▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

Market Analysis and Insights: Global Glycosylated Hemoglobin C-peptide Market
Due to the COVID-19 pandemic, the global Glycosylated Hemoglobin C-peptide market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Capsule accounting for % of the Glycosylated Hemoglobin C-peptide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Oncology segment is altered to an % CAGR throughout this forecast period.
China Glycosylated Hemoglobin C-peptide market size is valued at US$ million in 2021, while the US and Europe Glycosylated Hemoglobin C-peptide are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Glycosylated Hemoglobin C-peptide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Glycosylated Hemoglobin C-peptide include Pfizer Inc, Sandoz International GmbH, Sanofi, Roche Ltd, Celltrion Inc, Dr.Reddy’s Laboratories Ltd, Biocon Ltd and Medtronic, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Glycosylated Hemoglobin C-peptide Scope and Segment
Glycosylated Hemoglobin C-peptide market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Glycosylated Hemoglobin C-peptide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Capsule
Tablet
Others
Segment by Application
Oncology
Blood Disorder
Others
By Company
Pfizer Inc
Sandoz International GmbH
Sanofi
Roche Ltd
Celltrion Inc
Dr.Reddy’s Laboratories Ltd
Biocon Ltd
Medtronic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

---

1 Study Coverage
1.1 Glycosylated Hemoglobin C-peptide Product Introduction
1.2 Market by Type
1.2.1 Global Glycosylated Hemoglobin C-peptide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Others
1.3 Market by Application
1.3.1 Global Glycosylated Hemoglobin C-peptide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Blood Disorder
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Glycosylated Hemoglobin C-peptide Sales Estimates and Forecasts 2017-2028
2.2 Global Glycosylated Hemoglobin C-peptide Revenue Estimates and Forecasts 2017-2028
2.3 Global Glycosylated Hemoglobin C-peptide Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Glycosylated Hemoglobin C-peptide Sales by Region
2.4.1 Global Glycosylated Hemoglobin C-peptide Sales by Region (2017-2022)
2.4.2 Global Sales Glycosylated Hemoglobin C-peptide by Region (2023-2028)
2.5 Global Glycosylated Hemoglobin C-peptide Revenue by Region
2.5.1 Global Glycosylated Hemoglobin C-peptide Revenue by Region (2017-2022)
2.5.2 Global Glycosylated Hemoglobin C-peptide Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Glycosylated Hemoglobin C-peptide Sales by Manufacturers
3.1.1 Global Top Glycosylated Hemoglobin C-peptide Manufacturers by Sales (2017-2022)
3.1.2 Global Glycosylated Hemoglobin C-peptide Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Glycosylated Hemoglobin C-peptide in 2021
3.2 Global Glycosylated Hemoglobin C-peptide Revenue by Manufacturers
3.2.1 Global Glycosylated Hemoglobin C-peptide Revenue by Manufacturers (2017-2022)
3.2.2 Global Glycosylated Hemoglobin C-peptide Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Glycosylated Hemoglobin C-peptide Revenue in 2021
3.3 Global Glycosylated Hemoglobin C-peptide Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Glycosylated Hemoglobin C-peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Glycosylated Hemoglobin C-peptide Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Glycosylated Hemoglobin C-peptide Sales by Type
4.1.1 Global Glycosylated Hemoglobin C-peptide Historical Sales by Type (2017-2022)
4.1.2 Global Glycosylated Hemoglobin C-peptide Forecasted Sales by Type (2023-2028)
4.1.3 Global Glycosylated Hemoglobin C-peptide Sales Market Share by Type (2017-2028)
4.2 Global Glycosylated Hemoglobin C-peptide Revenue by Type
4.2.1 Global Glycosylated Hemoglobin C-peptide Historical Revenue by Type (2017-2022)
4.2.2 Global Glycosylated Hemoglobin C-peptide Forecasted Revenue by Type (2023-2028)
4.2.3 Global Glycosylated Hemoglobin C-peptide Revenue Market Share by Type (2017-2028)
4.3 Global Glycosylated Hemoglobin C-peptide Price by Type
4.3.1 Global Glycosylated Hemoglobin C-peptide Price by Type (2017-2022)
4.3.2 Global Glycosylated Hemoglobin C-peptide Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Glycosylated Hemoglobin C-peptide Sales by Application
5.1.1 Global Glycosylated Hemoglobin C-peptide Historical Sales by Application (2017-2022)
5.1.2 Global Glycosylated Hemoglobin C-peptide Forecasted Sales by Application (2023-2028)
5.1.3 Global Glycosylated Hemoglobin C-peptide Sales Market Share by Application (2017-2028)
5.2 Global Glycosylated Hemoglobin C-peptide Revenue by Application
5.2.1 Global Glycosylated Hemoglobin C-peptide Historical Revenue by Application (2017-2022)
5.2.2 Global Glycosylated Hemoglobin C-peptide Forecasted Revenue by Application (2023-2028)
5.2.3 Global Glycosylated Hemoglobin C-peptide Revenue Market Share by Application (2017-2028)
5.3 Global Glycosylated Hemoglobin C-peptide Price by Application
5.3.1 Global Glycosylated Hemoglobin C-peptide Price by Application (2017-2022)
5.3.2 Global Glycosylated Hemoglobin C-peptide Price Forecast by Application (2023-2028)
6 North America
6.1 North America Glycosylated Hemoglobin C-peptide Market Size by Type
6.1.1 North America Glycosylated Hemoglobin C-peptide Sales by Type (2017-2028)
6.1.2 North America Glycosylated Hemoglobin C-peptide Revenue by Type (2017-2028)
6.2 North America Glycosylated Hemoglobin C-peptide Market Size by Application
6.2.1 North America Glycosylated Hemoglobin C-peptide Sales by Application (2017-2028)
6.2.2 North America Glycosylated Hemoglobin C-peptide Revenue by Application (2017-2028)
6.3 North America Glycosylated Hemoglobin C-peptide Market Size by Country
6.3.1 North America Glycosylated Hemoglobin C-peptide Sales by Country (2017-2028)
6.3.2 North America Glycosylated Hemoglobin C-peptide Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Glycosylated Hemoglobin C-peptide Market Size by Type
7.1.1 Europe Glycosylated Hemoglobin C-peptide Sales by Type (2017-2028)
7.1.2 Europe Glycosylated Hemoglobin C-peptide Revenue by Type (2017-2028)
7.2 Europe Glycosylated Hemoglobin C-peptide Market Size by Application
7.2.1 Europe Glycosylated Hemoglobin C-peptide Sales by Application (2017-2028)
7.2.2 Europe Glycosylated Hemoglobin C-peptide Revenue by Application (2017-2028)
7.3 Europe Glycosylated Hemoglobin C-peptide Market Size by Country
7.3.1 Europe Glycosylated Hemoglobin C-peptide Sales by Country (2017-2028)
7.3.2 Europe Glycosylated Hemoglobin C-peptide Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Glycosylated Hemoglobin C-peptide Market Size by Type
8.1.1 Asia Pacific Glycosylated Hemoglobin C-peptide Sales by Type (2017-2028)
8.1.2 Asia Pacific Glycosylated Hemoglobin C-peptide Revenue by Type (2017-2028)
8.2 Asia Pacific Glycosylated Hemoglobin C-peptide Market Size by Application
8.2.1 Asia Pacific Glycosylated Hemoglobin C-peptide Sales by Application (2017-2028)
8.2.2 Asia Pacific Glycosylated Hemoglobin C-peptide Revenue by Application (2017-2028)
8.3 Asia Pacific Glycosylated Hemoglobin C-peptide Market Size by Region
8.3.1 Asia Pacific Glycosylated Hemoglobin C-peptide Sales by Region (2017-2028)
8.3.2 Asia Pacific Glycosylated Hemoglobin C-peptide Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Glycosylated Hemoglobin C-peptide Market Size by Type
9.1.1 Latin America Glycosylated Hemoglobin C-peptide Sales by Type (2017-2028)
9.1.2 Latin America Glycosylated Hemoglobin C-peptide Revenue by Type (2017-2028)
9.2 Latin America Glycosylated Hemoglobin C-peptide Market Size by Application
9.2.1 Latin America Glycosylated Hemoglobin C-peptide Sales by Application (2017-2028)
9.2.2 Latin America Glycosylated Hemoglobin C-peptide Revenue by Application (2017-2028)
9.3 Latin America Glycosylated Hemoglobin C-peptide Market Size by Country
9.3.1 Latin America Glycosylated Hemoglobin C-peptide Sales by Country (2017-2028)
9.3.2 Latin America Glycosylated Hemoglobin C-peptide Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Glycosylated Hemoglobin C-peptide Market Size by Type
10.1.1 Middle East and Africa Glycosylated Hemoglobin C-peptide Sales by Type (2017-2028)
10.1.2 Middle East and Africa Glycosylated Hemoglobin C-peptide Revenue by Type (2017-2028)
10.2 Middle East and Africa Glycosylated Hemoglobin C-peptide Market Size by Application
10.2.1 Middle East and Africa Glycosylated Hemoglobin C-peptide Sales by Application (2017-2028)
10.2.2 Middle East and Africa Glycosylated Hemoglobin C-peptide Revenue by Application (2017-2028)
10.3 Middle East and Africa Glycosylated Hemoglobin C-peptide Market Size by Country
10.3.1 Middle East and Africa Glycosylated Hemoglobin C-peptide Sales by Country (2017-2028)
10.3.2 Middle East and Africa Glycosylated Hemoglobin C-peptide Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Corporation Information
11.1.2 Pfizer Inc Overview
11.1.3 Pfizer Inc Glycosylated Hemoglobin C-peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Inc Glycosylated Hemoglobin C-peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Inc Recent Developments
11.2 Sandoz International GmbH
11.2.1 Sandoz International GmbH Corporation Information
11.2.2 Sandoz International GmbH Overview
11.2.3 Sandoz International GmbH Glycosylated Hemoglobin C-peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sandoz International GmbH Glycosylated Hemoglobin C-peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sandoz International GmbH Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Glycosylated Hemoglobin C-peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Glycosylated Hemoglobin C-peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Roche Ltd
11.4.1 Roche Ltd Corporation Information
11.4.2 Roche Ltd Overview
11.4.3 Roche Ltd Glycosylated Hemoglobin C-peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Roche Ltd Glycosylated Hemoglobin C-peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Roche Ltd Recent Developments
11.5 Celltrion Inc
11.5.1 Celltrion Inc Corporation Information
11.5.2 Celltrion Inc Overview
11.5.3 Celltrion Inc Glycosylated Hemoglobin C-peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Celltrion Inc Glycosylated Hemoglobin C-peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Celltrion Inc Recent Developments
11.6 Dr.Reddy’s Laboratories Ltd
11.6.1 Dr.Reddy’s Laboratories Ltd Corporation Information
11.6.2 Dr.Reddy’s Laboratories Ltd Overview
11.6.3 Dr.Reddy’s Laboratories Ltd Glycosylated Hemoglobin C-peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Dr.Reddy’s Laboratories Ltd Glycosylated Hemoglobin C-peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dr.Reddy’s Laboratories Ltd Recent Developments
11.7 Biocon Ltd
11.7.1 Biocon Ltd Corporation Information
11.7.2 Biocon Ltd Overview
11.7.3 Biocon Ltd Glycosylated Hemoglobin C-peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Biocon Ltd Glycosylated Hemoglobin C-peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biocon Ltd Recent Developments
11.8 Medtronic
11.8.1 Medtronic Corporation Information
11.8.2 Medtronic Overview
11.8.3 Medtronic Glycosylated Hemoglobin C-peptide Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Medtronic Glycosylated Hemoglobin C-peptide Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Medtronic Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Glycosylated Hemoglobin C-peptide Industry Chain Analysis
12.2 Glycosylated Hemoglobin C-peptide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Glycosylated Hemoglobin C-peptide Production Mode & Process
12.4 Glycosylated Hemoglobin C-peptide Sales and Marketing
12.4.1 Glycosylated Hemoglobin C-peptide Sales Channels
12.4.2 Glycosylated Hemoglobin C-peptide Distributors
12.5 Glycosylated Hemoglobin C-peptide Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Glycosylated Hemoglobin C-peptide Industry Trends
13.2 Glycosylated Hemoglobin C-peptide Market Drivers
13.3 Glycosylated Hemoglobin C-peptide Market Challenges
13.4 Glycosylated Hemoglobin C-peptide Market Restraints
14 Key Findings in The Global Glycosylated Hemoglobin C-peptide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

---